Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could removing a catheter sooner after kidney transplant cut infection risk?

NCT ID NCT07681843

Disease control Sponsor: Fahim Kanani Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This trial compares removing a urinary catheter on day 3 versus day 6 after a living donor kidney transplant. The goal is to see if earlier removal reduces urinary tract infections within 30 days without causing more complications like urine leaks. The study involves 172 adult kidney transplant recipients who have normal bladder function and are not at high risk for surgical problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If early removal works, it could lower infection rates and shorten hospital stays for kidney transplant recipients.
What could go wrong
This is a single-center trial with 172 participants, so results may not apply broadly. Early removal might increase urinary complications like leaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 172 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Undergoing living donor kidney transplantation * Pre-emptive kidney transplantation * Preserved urine output * Ability to provide written informed consent Exclusion Criteria: * Previous bladder or urethral surgery * Complex urinary tract reconstruction * Neurogenic bladder * Active urinary tract infection at the time of transplantation * Pregnancy * Body mass index (BMI) \<18 or \>40 kg/m² * Intraoperative blood loss \>1000 mL

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Catheter-associated urinary tract infections (cautis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure urinary tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Catheter-associated urinary tract infections (cautis) Kidney transplantation

Contacts and locations

Locations

  • Gray Faculty of Tel Aviv

    Petah Tikva, 4941492, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.